These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18644731)

  • 1. Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini.
    Ueno Y; Kawada K; Naito T; Shibata A; Yoshikawa K; Kim HS; Wataya Y; Kitade Y
    Bioorg Med Chem; 2008 Aug; 16(16):7698-704. PubMed ID: 18644731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini.
    Ueno Y; Kawada K; Shibata A; Yoshikawa K; Wataya Y; Kitade Y
    Nucleic Acids Symp Ser (Oxf); 2008; (52):503-4. PubMed ID: 18776474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
    Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-silencing properties of siRNAs that contain internal amide-bond linkages.
    Gong W; Desaulniers JP
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6934-7. PubMed ID: 23062704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of nuclease-resistant siRNAs possessing universal overhangs.
    Ueno Y; Watanabe Y; Shibata A; Yoshikawa K; Takano T; Kohara M; Kitade Y
    Bioorg Med Chem; 2009 Mar; 17(5):1974-81. PubMed ID: 19200743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference in mammalian cells by siRNAs modified with morpholino nucleoside analogues.
    Zhang N; Tan C; Cai P; Zhang P; Zhao Y; Jiang Y
    Bioorg Med Chem; 2009 Mar; 17(6):2441-6. PubMed ID: 19233658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of oligonucleotides carrying amino lipid groups at the 3'-end for RNA interference studies.
    Grijalvo S; Ocampo SM; Perales JC; Eritja R
    J Org Chem; 2010 Oct; 75(20):6806-13. PubMed ID: 20863084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference induced by siRNAs modified with 4'-thioribonucleosides in cultured mammalian cells.
    Hoshika S; Minakawa N; Kamiya H; Harashima H; Matsuda A
    FEBS Lett; 2005 Jun; 579(14):3115-8. PubMed ID: 15919084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
    Biochem Biophys Res Commun; 2012 Oct; 426(4):571-7. PubMed ID: 22982308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing.
    Myers JW; Jones JT; Meyer T; Ferrell JE
    Nat Biotechnol; 2003 Mar; 21(3):324-8. PubMed ID: 12592410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on aminoisonucleoside modified siRNAs: stability and silencing activity.
    Li ZS; Qiao RP; Du Q; Yang ZJ; Zhang LR; Zhang PZ; Liang ZC; Zhang LH
    Bioconjug Chem; 2007; 18(4):1017-24. PubMed ID: 17539595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino-modified and lipid-conjugated dicer-substrate siRNA enhances RNAi efficacy.
    Kubo T; Takei Y; Mihara K; Yanagihara K; Seyama T
    Bioconjug Chem; 2012 Feb; 23(2):164-73. PubMed ID: 22236254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-conjugated 27-nucleotide double-stranded RNAs with dicer-substrate potency enhance RNAi-mediated gene silencing.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
    Mol Pharm; 2012 May; 9(5):1374-83. PubMed ID: 22494497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of nuclease-resistant siRNAs possessing benzene-phosphate backbones in their 3'-overhang regions.
    Ueno Y; Inoue T; Yoshida M; Yoshikawa K; Shibata A; Kitamura Y; Kitade Y
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5194-6. PubMed ID: 18783944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing and utilization of siRNAs targeting RNA binding proteins.
    Kim DH; Behlke M; Rossi JJ
    Methods Mol Biol; 2008; 488():367-81. PubMed ID: 18982303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of thiophosphate substitutions on native siRNA gene silencing.
    Li ZY; Mao H; Kallick DA; Gorenstein DG
    Biochem Biophys Res Commun; 2005 Apr; 329(3):1026-30. PubMed ID: 15752758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.
    Yoo JW; Kim S; Lee DK
    Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-silencing potency of symmetric and asymmetric lipid-conjugated siRNAs and its correlation with dicer recognition.
    Kubo T; Yanagihara K; Sato Y; Nishimura Y; Kondo S; Seyama T
    Bioconjug Chem; 2013 Dec; 24(12):2045-57. PubMed ID: 24274056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
    Bartlett DW; Davis ME
    Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells.
    Czauderna F; Fechtner M; Dames S; Aygün H; Klippel A; Pronk GJ; Giese K; Kaufmann J
    Nucleic Acids Res; 2003 Jun; 31(11):2705-16. PubMed ID: 12771196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.